CANOPUS

CANOPUS predicts compound classes directly from tandem mass spectrometry (MS/MS) fragmentation spectra to enable systematic annotation and classification of metabolites, including unknowns lacking spectral or structural references.


Key Features:

  • Input: processes tandem mass spectrometry (MS/MS) fragmentation spectra as input.
  • Model: uses a deep neural network to assign spectra to compound classes.
  • Class coverage: assigns spectra into one of 2,497 biologically relevant compound classes.
  • Unknown compound classification: predicts compound classes without requiring spectral or structural reference data from existing libraries.
  • Evaluation: evaluated on reference datasets with cross-validation achieving an average accuracy of 99.7%.
  • Comparative performance: outperformed four baseline methods in comparative studies.

Scientific Applications:

  • Exploratory metabolomics: provides compound-class-level annotation to reveal chemical diversity in biological systems.
  • Natural product discovery: aids identification and characterization of novel natural products, including marine compounds.
  • Microbiome studies: applied to analyze chemical diversity changes during microbial colonization of the mouse digestive system.
  • Plant chemodiversity: applied to study chemodiversity in Euphorbia plants.

Methodology:

Uses a deep neural network to process MS/MS fragmentation spectra and assign them to one of 2,497 compound classes; performance was assessed on reference datasets using cross-validation (average accuracy 99.7%) and compared against four baseline methods.

Topics

Details

License:
MIT
Tool Type:
desktop application
Added:
1/18/2021
Last Updated:
11/3/2025

Operations

Data Inputs & Outputs

Publications

Dührkop K, Nothias L, Fleischauer M, Reher R, Ludwig M, Hoffmann MA, Petras D, Gerwick WH, Rousu J, Dorrestein PC, Böcker S. Systematic classification of unknown metabolites using high-resolution fragmentation mass spectra. Nature Biotechnology. 2020;39(4):462-471. doi:10.1038/s41587-020-0740-8. PMID:33230292.

PMID: 33230292
Funding: - Deutsche Forschungsgemeinschaft: BO 1910/20, PE 2600/1 - U.S. Department of Health & Human Services | National Institutes of Health: R01 GM107550, R01GM107550, R01GN107550 - EC | Horizon 2020 Framework Programme: 704786, MSCA-GF - Gordon and Betty Moore Foundation: GBMF7622 - Academy of Finland: 310107/MACOME

Links